These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18765312)

  • 1. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study.
    Murthy V; Thomas K; Foo K; Cunningham D; Johnson B; Norman A; Horwich A
    Clin Lymphoma Myeloma; 2008 Aug; 8(4):241-5. PubMed ID: 18765312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
    Chan EK; Fung S; Gospodarowicz M; Hodgson D; Wells W; Sun A; Pintile M; Tsang RW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e781-6. PubMed ID: 21167657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.
    Haas RL; Poortmans P; de Jong D; Verheij M; van der Hulst M; de Boer JP; Bartelink H
    Eur J Cancer; 2005 Aug; 41(12):1724-30. PubMed ID: 16039113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
    Rosenbluth BD; Yahalom J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
    Haas RL; Poortmans P; de Jong D; Aleman BM; Dewit LG; Verheij M; Hart AA; van Oers MH; van der Hulst M; Baars JW; Bartelink H
    J Clin Oncol; 2003 Jul; 21(13):2474-80. PubMed ID: 12829665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
    Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin's lymphoma.
    Verhappen MH; Poortmans PM; Raaijmakers E; Raemaekers JM
    Radiother Oncol; 2013 Oct; 109(1):133-9. PubMed ID: 24021344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
    Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
    J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma.
    Martens C; Hodgson DC; Wells WA; Sun A; Bezjak A; Pintilie M; Crump M; Gospodarowicz MK; Tsang R
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1183-7. PubMed ID: 16376490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Jóhannsson J; Specht L; Mejer J; Jensen BA
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1466-70. PubMed ID: 12459371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?
    Kahn S; Flowers C; Xu Z; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):175-80. PubMed ID: 20732769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Mazzarotto R; Boso C; Vianello F; Aversa MS; Chiarion-Sileni V; Trentin L; Zambello R; Muzzio PC; Fiore D; Sotti G
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):823-9. PubMed ID: 17379431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.
    Horning SJ; Weller E; Kim K; Earle JD; O'Connell MJ; Habermann TM; Glick JH
    J Clin Oncol; 2004 Aug; 22(15):3032-8. PubMed ID: 15210738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
    Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
    Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.
    Lowry L; Smith P; Qian W; Falk S; Benstead K; Illidge T; Linch D; Robinson M; Jack A; Hoskin P
    Radiother Oncol; 2011 Jul; 100(1):86-92. PubMed ID: 21664710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose radiotherapy in indolent lymphoma.
    Rossier C; Schick U; Miralbell R; Mirimanoff RO; Weber DC; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e1-6. PubMed ID: 21398049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.